Skip to main content
SpringerLink
Log in

Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Although selective serotonin reuptake inhibitors (SSRIs) produce clinical therapeutic effects on depression and anxiety through augmentation of serotonergic neurotransmission, there is little known about the potential contributions of the 5-HT6 receptor in the treatment of mood disorders.

Objectives

The aim of this study was to test the potential antidepressant-like and anxiolytic-like effects of the 5-HT6 receptor agonists WAY-208466 and WAY-181187 using established behavioral tests in rats.

Methods

In order to determine if the 5-HT6 receptor agonists possess antidepressant-like activity, rats were treated with WAY-208466 or WAY-181187 and tested in the modified rat forced swim test (FST). Also, the potential anxiolytic-like effects of WAY-208466 and WAY-181187 were measured using the defensive burying (DB) test and novelty-induced hypophagia (NIH) test.

Results

WAY-208466 and WAY-181187 produced both antidepressant-like and anxiolytic-like effects. Both compounds decreased immobility and increased swimming behavior in the FST. The effects of the 5-HT6 receptor agonists were similar to those seen after treatment with the SSRI fluoxetine. Both 5-HT6 receptor agonists also decreased burying duration in the DB test, indicative of anxiolytic activity in the test. The anxiolytic effects of WAY-208466 were reproduced in the NIH test. Assessment of the anxiolytic effects of WAY-181187 in the NIH was confounded by alterations in home cage feeding behavior.

Conclusions

These findings suggest that 5-HT6 receptor agonists may represent a new class of potential antidepressant and anxiolytic compounds and could possess a number of advantages over currently available treatments, including rapid onset of anxiolytic efficacy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Bechtholt AJ, Hill TE, Lucki I (2007) Anxiolytic effect of serotonin depletion in the novelty-induced hypophagia test. Psychopharmacology (Berl) 190:531–540

    Article  CAS  Google Scholar 

  • Bechtholt AJ, Valentino RJ, Lucki I (2008) Overlapping and distinct brain regions associated with the anxiolytic effects of chlordiazepoxide and chronic fluoxetine. Neuropsychopharmacology 33:2117–2130

    Article  CAS  PubMed  Google Scholar 

  • Blier P, Ward NM (2003) Is there a role for 5-HT1A agonists in the treatment of depression? Biol Psychiatry 53:193–203

    Article  CAS  PubMed  Google Scholar 

  • Bodnoff SR, Suranyl-Cadotte B, Aitken DH, Quirion R, Meaney MJ (1988) The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology 95:298–302

    Article  CAS  PubMed  Google Scholar 

  • Bodnoff SR, Suranyl-Cadotte B, Quirion R, Meaney MJ (1989) A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology 97:277–279

    Article  CAS  PubMed  Google Scholar 

  • Bondi CO, Barrera G, Lapiz MD, Bedard T, Mahan A, Morilak DA (2007) Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine. Prog Neuropsychopharmacol Biol Psychiatry 31:482–495

    Article  CAS  PubMed  Google Scholar 

  • Borsini F (1995) Role of the serotonergic system in the forced swimming test. Neurosci Biobehav Rev 19:377–395

    Article  CAS  PubMed  Google Scholar 

  • Burnham KE, Baxter MG, Bainton JR, Southam E, Dawson LA, Bannerman DM, Sharp T (2010) Activation of 5-HT(6) receptors facilitates attentional set shifting. Psychopharmocology (Berl) 208:13–21

    Article  CAS  Google Scholar 

  • Carr GV, Lucki I (2010) Role for serotonin in depression. In: Muller C, Jacobs B (eds) Handbook of the behavioral neurobiology of serotonin. Academic, Amsterdam, pp 493–505

    Chapter  Google Scholar 

  • Cole DC, Stock JR, Lennox WJ, Bernotas RC, Ellingboe JW, Boikess S, Coupet J, Smith DL, Leung L, Zhang GM, Feng X, Kelly MF, Galante R, Huang P, Dawson LA, Marquis K, Rosenzweig-Lipson S, Beyer CE, Schechter LE (2007) Discovery of N1-(6-chloroimidazo[2, 1-b][1, 3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist. J Med Chem 50:5535–5538

    Article  CAS  PubMed  Google Scholar 

  • Cryan JF, Valentino RJ, Lucki I (2005) Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29:547–569

    Article  CAS  PubMed  Google Scholar 

  • Dawson LA, Nguyen HQ, Li P (2000) In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate. Br J Pharmacol 130:23–26

    Article  CAS  PubMed  Google Scholar 

  • Dawson LA, Nguyen HQ, Li P (2001) The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 25:662–668

    Article  CAS  PubMed  Google Scholar 

  • De Boer SF, Koolhaas JM (2003) Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur J Pharmacol 463:145–161

    Article  PubMed  Google Scholar 

  • Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121:66–72

    Article  CAS  Google Scholar 

  • De Vry J (1995) 5-HT1A receptor agonists: recent developments and controversial issues. Psychopharmacology (Berl) 121:1–26

    Article  Google Scholar 

  • Dulawa SC, Hen R (2005) Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci Biobehav Rev 29:771–783

    Article  CAS  PubMed  Google Scholar 

  • Dulawa SC, Holick KA, Gundersen B, Hen R (2004) Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29:1321–1330

    Article  CAS  PubMed  Google Scholar 

  • Fisas A, Codony X, Romero G, Dordal A, Giraldo J, Merce R, Holenz J, Vrang N, Sorensen RV, Heal D, Buschmann H, Pauwels PJ (2006) Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats. Br J Pharmacol 148:973–983

    Article  CAS  PubMed  Google Scholar 

  • Fone KC (2008) An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function. Neuropharmacology 55:1015–1022

    Article  CAS  PubMed  Google Scholar 

  • Frazer A (1997) Pharmacology of antidepressants. J Clin Psychopharmacol 17(Suppl 1):2S–18S

    Article  CAS  PubMed  Google Scholar 

  • Gerard C, el Mestikawy S, Lebrand C, Adrien J, Ruat M, Traiffort E, Hamon M, Martres MP (1996) Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats. Synapse 23:164–173

    Article  CAS  PubMed  Google Scholar 

  • Gerard C, Martres MP, Lefevre K, Miquel MC, Verge D, Lanfumey L, Doucet E, Hamon M, el Mestikawy S (1997) Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Res 746:207–219

    Article  CAS  PubMed  Google Scholar 

  • Hamon M, Doucet E, Lefevre K, Miquel MC, Lanfumey L, Insausti R, Frechilla D, Del Rio J, Verge D (1999) Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5-HT6 receptors. Neuropsychopharmacology 21(Suppl):68S–76S

    CAS  PubMed  Google Scholar 

  • Hatcher PD, Brown VJ, Tait DS, Bate S, Overend P, Hagan JJ, Jones DN (2005) 5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats. Psychopharmacology (Berl) 181:253–259

    Article  CAS  Google Scholar 

  • Hirano K, Piers TM, Searle KL, Miller ND, Rutter AR, Chapman PF (2009) Procognitive 5-HT6 antagonists in the rat forced swimming test: potential therapeutic utility in mood disorders associated with Alzheimer's disease. Life Sci 84:558–562

    Article  CAS  PubMed  Google Scholar 

  • Hirst WD, Stean TO, Rogers DC, Sunter D, Pugh P, Moss SF, Bromidge SM, Riley G, Smith DR, Bartlett S, Heidbreder CA, Atkins AR, Lacroix LP, Dawson LA, Foley AG, Regan CM, Upton N (2006) SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models. Eur J Pharmacol 553:109–119

    Article  CAS  PubMed  Google Scholar 

  • Loiseau F, Dekeyne A, Millan MJ (2008) Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex. Psychopharmacology (Berl) 196:93–104

    Article  CAS  Google Scholar 

  • Lucki I (1997) The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8:523–532

    Article  CAS  PubMed  Google Scholar 

  • Lucki I, Singh A, Kreiss DS (1994) Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci Biobehav Rev 18:85–95

    Article  CAS  PubMed  Google Scholar 

  • Mayorga AJ, Dalvi A, Page ME, Zimov-Levinson S, Hen R, Lucki I (2001) Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine (1B) receptor mutant mice. J Pharmacol Exp Ther 298:1101–1107

    CAS  PubMed  Google Scholar 

  • Mitchell ES, Neumaier JF (2005) 5-HT6 receptors: a novel target for cognitive enhancement. Pharmacol Ther 108:320–333

    Article  CAS  PubMed  Google Scholar 

  • Monsma FJ Jr, Shen Y, Ward RP, Hamblin MW, Sibley DR (1993) Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 43:320–327

    CAS  PubMed  Google Scholar 

  • Montgomery SA, Baldwin DS, Blier P, Fineberg NA, Kasper S, Lader M, Lam RW, Lepine JP, Moller HJ, Nutt DJ, Rouillon F, Schatzberg AF, Thase ME (2007) Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol 22:323–329

    Article  PubMed  Google Scholar 

  • Nutt DJ (2005) Overview of diagnosis and drug treatments of anxiety disorders. CNS Spectr 10:49–56

    PubMed  Google Scholar 

  • Riemer C, Borroni E, Levet-Trafit B, Martin JR, Poli S, Porter RH, Bos M (2003) Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist. J Med Chem 46:1273–1276

    Article  CAS  PubMed  Google Scholar 

  • Roberts JC, Reavill C, East SZ, Harrison PJ, Patel S, Routledge C, Leslie RA (2002) The distribution of 5-HT(6) receptors in the rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585. Brain Res 934:49–57

    Article  CAS  PubMed  Google Scholar 

  • Rogers DC, Hagan JJ (2001) 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology (Berl) 158:114–119

    Article  CAS  Google Scholar 

  • Ruat M, Traiffort E, Arrang JM, Tardivel-Lacombe J, Diaz J, Leurs R, Schwartz JC (1993) A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem Biophys Res Commun 193:268–276

    Article  CAS  PubMed  Google Scholar 

  • Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805–809

    Article  CAS  PubMed  Google Scholar 

  • Schechter LE, Lin Q, Smith DL, Zhang G, Shan Q, Platt B, Brandt MR, Dawson LA, Cole D, Bernotas R, Robichaud A, Rosenzweig-Lipson S, Beyer CE (2008) Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacology 33:1323–1335

    Article  CAS  PubMed  Google Scholar 

  • Shiah IS, Yatham LN (1998) GABA function in mood disorders: an update and critical review. Life Sci 63:1289–1303

    Article  CAS  PubMed  Google Scholar 

  • Svenningsson P, Tzavara ET, Qi H, Carruthers R, Witkin JM, Nomikos GG, Greengard P (2007) Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation. J Neurosci 27:4201–4209

    Article  CAS  PubMed  Google Scholar 

  • Treit D, Pesold C (1990) Septal lesions inhibit fear reactions in two animal models of anxiolytic drug action. Physiol Behav 47:365–371

    Article  CAS  PubMed  Google Scholar 

  • Treit D, Pinel JP, Fibiger HC (1981) Conditioned defensive burying: a new paradigm for the study of anxiolytic agents. Pharmacol Biochem Behav 15:619–626

    Article  CAS  PubMed  Google Scholar 

  • Ward RP, Hamblin MW, Lachowicz JE, Hoffman BJ, Sibley DR, Dorsa DM (1995) Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry. Neuroscience 64:1105–1111

    Article  CAS  PubMed  Google Scholar 

  • Ward SJ, Lefever TW, Jackson C, Tallarida RJ, Walker EA (2008) Effects of a Cannabinoid1 receptor antagonist and Serotonin2C receptor agonist alone and in combination on motivation for palatable food: a dose-addition analysis study in mice. J Pharmacol Exp Ther 325:567–576

    Article  CAS  PubMed  Google Scholar 

  • Wesolowska A (2007) Study into a possible mechanism responsible for the antidepressant-like activity of the selective 5-HT6 receptor antagonist SB-399885 in rats. Pharmacol Rep 59:664–671

    CAS  PubMed  Google Scholar 

  • Wesolowska A (2008) The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors. Eur J Pharmacol 580:355–360

    Article  CAS  PubMed  Google Scholar 

  • Wesolowska A, Nikiforuk A (2007) Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. Neuropharmacology 52:1274–1283

    Article  CAS  PubMed  Google Scholar 

  • Wesolowska A, Nikiforuk A (2008) The selective 5-HT6 receptor antagonist SB-399885 enhances anti-immobility action of antidepressant in rats. Eur J Pharmacol 582:88–93

    Article  CAS  PubMed  Google Scholar 

  • Wesolowska A, Nikiforuk A, Stachowicz K (2007) Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats. Behav Pharmacol 18:439–446

    Article  CAS  PubMed  Google Scholar 

  • Woods A, Smith C, Szewczak M, Dunn RW, Cornfeldt M, Corbett R (1993) Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder. Psychopharmacology (Berl) 112:195–198

    Article  CAS  Google Scholar 

  • Woolley ML, Marsden CA, Sleight AJ, Fone KC (2003) Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790. Psychopharmacology (Berl) 170:358–367

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge the technical assistance of Karen Smith and Stephanie Gaughan in the execution of the FST experiments. This study was supported by a National Cooperative Drug Discovery Group in Mood Disorders established between the University of Pennsylvania and Wyeth Research MH72832, the Training Program in Neuropsychopharmacology at the University of Pennsylvania T32-MH14652, and Wyeth Research.

Author information

Author notes

  1. Lee E. Schechter

    Present address: Pfizer, External R&D Innovation, Princeton, NJ, 08543, USA

Authors and Affiliations

  1. Department of Psychiatry, University of Pennsylvania, 125 South 31st Street, Room 2204, Philadelphia, PA, 19104, USA

    Gregory V. Carr & Irwin Lucki

  2. Department of Pharmacology, University of Pennsylvania, Philadelphia, PA, USA

    Gregory V. Carr & Irwin Lucki

  3. Wyeth Research, Princeton, NJ, 08852, USA

    Lee E. Schechter

Authors
  1. Gregory V. Carr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lee E. Schechter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Irwin Lucki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Irwin Lucki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carr, G.V., Schechter, L.E. & Lucki, I. Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats. Psychopharmacology 213, 499–507 (2011). https://doi.org/10.1007/s00213-010-1798-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-010-1798-7

Keywords

Search

Navigation